A.R.T. Advisors, LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 125 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$138,000
+74.7%
41,788
+8.9%
0.01%
+75.0%
Q3 2019$79,000
-48.4%
38,388
-26.0%
0.00%
-55.6%
Q2 2019$153,000
+44.3%
51,874
+82.1%
0.01%
+50.0%
Q1 2019$106,000
+1.9%
28,485
+9.2%
0.01%
-14.3%
Q4 2018$104,000
-43.2%
26,082
-10.1%
0.01%
-22.2%
Q3 2017$183,000
-81.8%
28,998
-77.5%
0.01%
-83.0%
Q2 2017$1,008,000
-38.9%
128,698
-55.0%
0.05%
-13.1%
Q3 2015$1,651,000
+660.8%
285,743
+973.5%
0.06%
+771.4%
Q1 2015$217,000
-86.4%
26,619
-83.6%
0.01%
-90.5%
Q3 2014$1,599,000162,3880.07%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders